Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study：Disease Outcome and Safety of JT001 in Patients With Coronavirus Disease 2019 (COVID-19)

NCT06142201 is registered in ClinicalTrials.gov with Shanghai Vinnerna Biosciences Co., Ltd. as lead sponsor.

NCT NCT06142201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06142201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study：Disease Outcome and Safety of JT001 in Patients With Coronavirus Disease 2019 (COVID-19)
Lead sponsor
Shanghai Vinnerna Biosciences Co., Ltd.
Phase
Observational
Overall status
Active, not recruiting
Start date
August 31, 2023
Completion date
December 31, 2024
Enrollment
7,656 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19